Bacillus Calmette-Guerin

Bladder Cancer Therapy by ImmunityBio gets FDA Approval

Health regulators in the United States on Monday approved ImmunityBio’s combination therapy for the treatment of a type of bladder cancer. This ends the company's struggles to bring the drug to the market.